OR WAIT null SECS
July 06, 2020
Lonza is making additional investments in its global particle engineering network for expanded capacity and specialized capabilities.
July 02, 2020
Demand for custom drug delivery solutions is increasing and bringing forth an exciting period of valuable, innovative development opportunities.
Controlled-release formulations offer numerous advantages for developers and patients, and this market is expected to continue to experience growth in the near future.
June 02, 2020
The correct mix of excipients is crucial to the success of fast dissolving/orally disintegrating dosage forms.
Increasing prevalence of drug misuse and abuse is driving a heightened and more stringent approach to abuse-deterrent formulations.
Connected delivery solutions can provide value to industry and patients, through improved medication adherence and outcome optimization.
The authors compare formulations containing citrate with other buffers in reducing subcutaneous injection-site pain and discuss a formulation and excipients selection strategy.
May 04, 2020
Kindeva Drug Delivery plans capital investment and jobs growth.
April 14, 2020
With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.
April 06, 2020
A quick look at the history of OTC dosage form development shows the importance of patient-centered innovation.